The relative mRNA of folr1 showed markedly increased levels in MB (about 10.0-fold compared with normal tissues), but little expression in benign tumors like pituitary adenomas and meningiomas (about 1.5-fold and 2.0-fold respectively, Figure 1D). This evidence concerns the gene FOLR1 and benign neoplasm.